3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Sarcoma
17
CNS
5
Other solid neoplasm
3
Lymphoid
3
Genitourinary
3
Gastrointestinal
3
Other hematologic neoplasm
2
Gynecologic
2
Dermatologic
2
Breast
2
Thoracic
1
Head & Neck
1
Endocrine
1
Classical hematology
1
Conditions
Lung Neoplasms
1366
Carcinoma, Non-Small-Cell Lung
1079
Breast Neoplasms
183
Neoplasms
144
Small Cell Lung Carcinoma
137
Colorectal Neoplasms
104
Adenocarcinoma of Lung
86
Melanoma
84
Prostatic Neoplasms
80
Pancreatic Neoplasms
79
Esophageal Neoplasms
70
Head and Neck Neoplasms
69
Ovarian Neoplasms
67
Colonic Neoplasms
67
Stomach Neoplasms
63
Urinary Bladder Neoplasms
49
Neoplasm Metastasis
49
Disease
48
Mesothelioma
44
Liver Neoplasms
44
Pulmonary Disease, Chronic Obstructive
42
Mesothelioma, Malignant
42
Brain Neoplasms
37
Lung Diseases
36
Carcinoma, Renal Cell
35
Uterine Cervical Neoplasms
34
Pleural Effusion, Malignant
34
Kidney Neoplasms
33
NSCLC
31
Carcinoma
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Rhabdomyosarcoma
×
Thoracic
×
Clear all
NCT05697198
2025-03-06
PREFER
Labcorp Corporation of America Holdings, Inc
Completed
1,429 enrolled